The revolutionary genetic test helps screen common genes associated with hereditary breast and ovarian cancer in women above 18 years of age
NATCO and Teva are launching these strengths of lenalidomide pursuant to a license of patents owned by Celgene
Novel delivery of established growth and neurotrophic factors enables local, sustained release for greater efficacy
This ninth update of WHO’s guideline on therapeutics includes a recommendation that casirivimab-imdevimab not be used for patients infected with the Omicron variant
The sNDA was supported by the clinical results from cohort B of a single-arm, multi-center, pivotal study (RELIANCE study) on Carteyva in adult patients with relapsed or refractory B cell non-hodgkin lymphoma in China
This medicine was previously available in 40mg and 80mg strength, for which patients had to consume 2 tablets a day as per the approved dosage
Methodology developed by QIMR Berghofer researchers utilizing the Agilent Cary 630 FTIR
It is used to control, prevent and normalize the symptoms associated with Alzheimer's disease, attention disorder, bipolar disorder, Parkinson's disease among others
The SureSTART consumables portfolio is designed for higher performance requirements, while meeting customer budgets
The sale is expected to close in the first quarter of 2022
Subscribe To Our Newsletter & Stay Updated
